These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
348 related items for PubMed ID: 12499816
21. Correlation between intrahepatic hepatitis B virus cccDNA levels and other activity markers in patients with HBeAg-negative chronic hepatitis B infection. Guner R, Karahocagil M, Buyukberber M, Kandemir O, Ural O, Usluer G, Inan D, Koksal I, Baykam N, Hizel K, Yamazhan T, Esen S, Tasyaran MA. Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1185-91. PubMed ID: 21934508 [Abstract] [Full Text] [Related]
22. Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus related liver disease. Mohamadnejad M, Montazeri G, Fazlollahi A, Zamani F, Nasiri J, Nobakht H, Forouzanfar MH, Abedian S, Tavangar SM, Mohamadkhani A, Ghoujeghi F, Estakhri A, Nouri N, Farzadi Z, Najjari A, Malekzadeh R. Am J Gastroenterol; 2006 Nov; 101(11):2537-45. PubMed ID: 17029616 [Abstract] [Full Text] [Related]
23. There were no differences in serum HBV DNA level between HBeAg-positive and HBeAg-negative chronic hepatitis B with same liver histological necroinflammation grade but differences among grades 1, 2, 3 and 4 apportioned by the same hepatic parenchyma cell volume. Ke WM, Xie SB, Li XJ, Zhang SQ, Lai J, Ye YN, Gao ZL, Chen PJ. J Viral Hepat; 2011 Sep; 18(9):637-45. PubMed ID: 21794025 [Abstract] [Full Text] [Related]
24. Evaluation of normal or minimally elevated alanine transaminase, age and DNA level in predicting liver histological changes in chronic hepatitis B. Alam S, Ahmad N, Mustafa G, Shrestha A, Alam AK, Khan M. Liver Int; 2011 Jul; 31(6):824-30. PubMed ID: 21645213 [Abstract] [Full Text] [Related]
25. Circulating IL-2, IL-10 and TNF-alpha in chronic hepatitis B: their relations to HBeAg status and the activity of liver disease. Bozkaya H, Bozdayi M, Türkyilmaz R, Sarioglu M, Cetinkaya H, Cinar K, Köse K, Yurdaydin C, Uzunalimoglu O. Hepatogastroenterology; 2000 Jul; 47(36):1675-9. PubMed ID: 11149030 [Abstract] [Full Text] [Related]
28. [Characteristic of liver pathology in HBeAg-positive and HBeAg-negative chronic hepatitis B patients with mildly elevated ALT]. Liu SQ, Zhu XJ, Sun XH, Li M, Gao YQ. Zhonghua Gan Zang Bing Za Zhi; 2012 May; 20(5):348-52. PubMed ID: 22971279 [Abstract] [Full Text] [Related]
29. Chronic carriers of hepatitis B virus in Bangladesh: a comparative analysis of HBV-DNA, HBeAg/anti-HBe, and liver function tests. Hasan KN, Rumi MA, Hasanat MA, Azam MG, Ahmed S, Salam MA, Islam LN, Hassan MS. Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):110-7. PubMed ID: 12118438 [Abstract] [Full Text] [Related]
30. Decreasing hepatitis B viral load is associated with a risk of significant liver fibrosis in hepatitis B e antigen positive chronic hepatitis B. Xie Q, Hu X, Zhang Y, Jiang X, Li X, Li J. J Med Virol; 2014 Nov; 86(11):1828-37. PubMed ID: 25145769 [Abstract] [Full Text] [Related]
31. Dynamics of hepatitis B e antigen index ratio correlate with treatment response in chronic hepatitis B patients. Wang CC, Liu CJ, Lai MY, Kao JH, Chen DS. Liver Int; 2007 Mar; 27(2):235-9. PubMed ID: 17311619 [Abstract] [Full Text] [Related]
32. Evaluation of liver biopsy in Egyptian HBeAg-negative chronic hepatitis B patients at initial presentation: implications for therapy. El-Zayadi AR, Badran HM, Saied A, Shawky S, Attia Mel-D, Zalata K. Am J Gastroenterol; 2009 Apr; 104(4):906-11. PubMed ID: 19293791 [Abstract] [Full Text] [Related]
33. [Hepatic steatosis: a common reason for elevated alanine aminotransferase levels in HBsAg-positive chronic hepatitis B patients with low HBV DNA loads]. Shi JP, Fan JG, Lou GQ, Zhang L, Hu CB, Wu R, Xun YH. Zhonghua Gan Zang Bing Za Zhi; 2008 Nov; 16(11):818-22. PubMed ID: 19032864 [Abstract] [Full Text] [Related]
34. Hepatitis B virus genotypes and G1896A precore mutation in 486 Spanish patients with acute and chronic HBV infection. Rodriguez-Frias F, Jardi R, Buti M, Schaper M, Hermosilla E, Valdes A, Allende H, Martell M, Esteban R, Guardia J. J Viral Hepat; 2006 May; 13(5):343-50. PubMed ID: 16637866 [Abstract] [Full Text] [Related]
35. Combined branched-DNA and conventional HBV PCR assays for detection of serum HBV-DNA in hepatitis B e antigen-positive chronic hepatitis B patients. Ozdarendeli A, Toroman ZA, Bulut Y, Demirbag K, Kalkan A, Ozden M, Kilic SS. Hepatogastroenterology; 2006 May; 53(67):106-9. PubMed ID: 16506386 [Abstract] [Full Text] [Related]
36. [Correlation of serum chemokine RANTES level with serum biochemical indices, HBeAg and HBV DNA load in patients with chronic hepatitis B]. Zhang K, Xu QH, Chen LB, Shu X, Chen N, Li G. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Jun; 23(3):188-90. PubMed ID: 20104774 [Abstract] [Full Text] [Related]
37. Combination of baseline parameters and on-treatment hepatitis B virus DNA levels to start and continue patients with lamivudine therapy. Yuen MF, Fung J, Seto WK, Wong DK, Yuen JC, Lai CL. Antivir Ther; 2009 Jun; 14(5):679-85. PubMed ID: 19704171 [Abstract] [Full Text] [Related]
38. An extended two-year trial of lamivudine in Chinese patients with chronic hepatitis B. Yao G, Cui Z, Wang B, Yao J, Zeng M. Chin Med J (Engl); 2002 Dec; 115(12):1814-8. PubMed ID: 12622930 [Abstract] [Full Text] [Related]
39. Increasing hepatitis B viral load is associated with risk of significant liver fibrosis in HBeAg-negative but not HBeAg-positive chronic hepatitis B. Croagh CM, Bell SJ, Slavin J, Kong YX, Chen RY, Locarnini S, Desmond PV. Liver Int; 2010 Sep; 30(8):1115-22. PubMed ID: 20492511 [Abstract] [Full Text] [Related]
40. [Hepatitis B virus genotypes and alanine aminotransferase levels in HBeAg negative patients with chronic hepatitis B and liver cirrhosis]. Li JQ, Zhuang H, Du H, Wang XH, Duan XZ. Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):491-3. PubMed ID: 16042881 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]